Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00836602 | Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-779788 in Healthy Subjects | PHASE1 | COMPLETED | 25 | — | — | Feb 1, 2009 | Jul 1, 2009 | Feb 23, 2011 | 1 | Australia |
| Arm | Type | Description |
|---|---|---|
| BMS-779788 or Placebo (Arm 1) | ACTIVE_COMPARATOR | - |
| BMS-779788 or Placebo (Arm 2) | ACTIVE_COMPARATOR | - |
| BMS-779788 or Placebo (Arm 3) | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| BMS-779788 | DRUG | Oral Solution, Oral, 1 mg, Once daily, 7 days |
| Placebo | DRUG | Oral Solution, Oral, 0 mg, Once daily, 7 days |
Inclusion Criteria: * Men and women (not of child bearing potential) ages 18 to 45 * Healthy subjects as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations Exclusion Criteria: * Women of child bearin...